恩诺沙星小鼠单抗
-
产品编号
PA098
-
别名
恩诺沙星, 恩诺沙星单抗, Enrofloxacin
-
规格
- 100μl
- 200μl
产品介绍
| Alias | 恩诺沙星, 恩诺沙星单抗, Enrofloxacin |
| Catalog Number | PA098 |
| Molecular Name | Enrofloxacin |
| Size | 100μl,200μl |
| Clonity | Monoclonal Antibody |
| Concentration | 1mg/ml |
| Purification | Protein A/G |
| Formulation | 0.01M PBS (pH 7.4) containning 10% glycerol. |
| Background | Enrofloxacin (ENR) is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently approved by the FDA for the treatment of individual pets and domestic animals in the United States. In September 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen.It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication. Enrofloxacin is partially deethylated by CYP450 into the active metabolite ciprofloxacin, which is also a fluoroquinolone antibiotic. |
| Immunogen | BSA conjugated enrofloxacin |
| Application | ELISA, POCT |
| Storage Condition | Store at -20 ℃ for 3 months, -70 ℃ for 12 months |
| Cross-reactivity | This antibody is specific for enrofloxacin antigen and does not react with other molecules. |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
